Table 1.
Association between BUB1B expression and clinicopathological features in patients with HCC (n = 80)
Characteristics | Number | BUB1B expression | P‐value | |
---|---|---|---|---|
Low group |
High group | |||
Age(years) | ||||
<50 | 23 | 10 | 13 | .459 |
≥50 | 57 | 30 | 27 | |
Gender | ||||
Female | 27 | 10 | 17 | .098 |
Male | 53 | 30 | 23 | |
Cirrhosis | ||||
Present | 67 | 35 | 32 | .363 |
Absent | 13 | 5 | 8 | |
HBV infection | ||||
Positive | 70 | 34 | 36 | .499 |
Negative | 10 | 6 | 4 | |
Tumor size(cm) | ||||
<5 | 44 | 31 | 13 | P < .001 *** |
≥5 | 36 | 9 | 27 | |
Microvascular invasion | ||||
Presence | 38 | 10 | 28 | P < .001 *** |
Absence | 42 | 30 | 12 | |
Tumor multiplicity | ||||
Simple | 38 | 24 | 14 | .025 * |
Multiple | 42 | 16 | 26 | |
α‐Fetoprotein (ng/ml) | ||||
≤20 | 43 | 20 | 23 | .501 |
>20 | 37 | 20 | 17 | |
TNM stage | ||||
I | 36 | 24 | 12 | .007 ** |
II/III | 44 | 16 | 28 | |
Edmonson stage | ||||
I/II | 42 | 28 | 14 | .002 ** |
III/IV | 38 | 12 | 26 |
P < .05
P < .01
P < .001